In cancer cells, transcriptional activators, such as Nrf2 and HIF-1, are expressed at higher levels and outcompete Bach1 for sMAF binding, resulting in the transcription of HO-1 [41,42]. The gene discussed is NFE2L2; the disease is cancer.